Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=161"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=161

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03298945-sae",
        "title": "Golytely vs Miralax-Gatorade Prep: serious adverse events",
        "summary": "6 of 1139 against 5 of 1100; risk difference 0.1 points, 95% interval -0.6 to 0.7; NCT03298945, Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens",
        "record": "/library/comparisons/NCT03298945-sae",
        "nct_id": "NCT03298945",
        "kind": "serious-adverse-events",
        "participants": 2239,
        "risk_difference": {
          "value": 0.0007223242078378163,
          "lower": -0.005966679090135514,
          "upper": 0.00742537134907077
        },
        "group_1": "6 of 1,139",
        "group_2": "5 of 1,100",
        "difference": "0.1 points",
        "interval": "-0.6 to 0.7",
        "trial_title": "Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens"
      },
      {
        "id": "NCT00619359-0c850ea6",
        "title": "Fosaprepitant vs Aprepitant: No Vomiting Overall (in the 120 Hours Following Initiation of Cisplatin)",
        "summary": "806 of 1106 against 844 of 1132; risk difference -1.7 points, 95% interval -5.3 to 2.0; NCT00619359, Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)",
        "record": "/library/comparisons/NCT00619359-0c850ea6",
        "nct_id": "NCT00619359",
        "kind": "outcome",
        "participants": 2238,
        "risk_difference": {
          "value": -0.016830778471427887,
          "lower": -0.05326852087211246,
          "upper": 0.019624987413915995
        },
        "group_1": "806 of 1,106",
        "group_2": "844 of 1,132",
        "difference": "-1.7 points",
        "interval": "-5.3 to 2.0",
        "trial_title": "Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=162",
  "request_id": "sML_ebHvFenhNlF9"
}